Synthorx
Established in 2014, Synthorx conducts research on and manufactures bio pharmaceuticals that target cancerous cells. Some of the types of cancer that are treated include melanoma, aldesleukin, and more. This company is headquartered in La Jolla, California.
Last updated on
About Synthorx
Founded
2014Estimated Revenue
$10M-$50MEmployees
11-50Funding / Mkt. Cap
$230MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
87NAICs Code
541713Location
City
La JollaState
CaliforniaCountry
United StatesSynthorx
Find your buyer within Synthorx